Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids

Shin Nieh, Su Feng Chen, Earl Fu, Chi Ing Jan, Wei Hua Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To apply in situ hybridization (ISH) detection of human telomerase reverse transcriptase (hTERT) mRNA expression in abnormal cells in body fluids to evaluate its usefulness in the diagnosis of malignant effusions. Study Design: We investigated the expression of hTERT mRNA by ISH in 33 fluid samples from 30 patients, including 1 cerebrospinal fluid, 18 pleural fluids, 1 pericardial fluid, 12 peritoneal fluids and 1 bronchial washing. Comparison of the results of ISH with those of conventional cytologic evaluation was also performed. Results: Cytomorphologic examination of the 33 body fluids allowed classification as malignant, suspicious, atypical and benign conditions. Among the 17 malignant conditions, there were 15 cases positive by both cytology and ISH. There were 9 discrepant cytology-ISH results in patients with various conditions, including 2 cases positive by cytology and inconclusive by ISH, 5 cases suspicious by cytology and positive by ISH, and 2 cases atypical by cytology and negative by ISH. Among the 9 benign conditions, there were 8 cases negative by both cytology and ISH and 1 case negative by cytology and positive by ISH. This test was highly sensitive (90%) and specific (91 %) and had favorable positive (95%) and negative (83%) predictive values. Conclusion: Expression of the hTERT mRNA component can be easily detected by ISH in malignant cells from body fluids. This method is especially useful when the abnormal cell population in the fluid consists of limited numbers of suspicious cells that cannot be completely differentiated from reactive mesothelial cells and thus may help differentiate true positive cases from false negative ones. This ISH method for the detection of expression of the hTERT mRNA component may be an ancillary test for early recognition of cancer cells in body fluids and thus has potential as a diagnostic adjunct in cytopathology.

Original languageEnglish
Pages (from-to)31-37
Number of pages7
JournalActa Cytologica
Volume49
Issue number1
Publication statusPublished - 2005
Externally publishedYes

Fingerprint

Body Fluids
In Situ Hybridization
Cell Biology
Messenger RNA
Cell Body
telomerase RNA
Ascitic Fluid
Cerebrospinal Fluid
Cell Count

Keywords

  • Body fluids
  • Fluid cytology
  • Human telomerase reverse transcriptase
  • Hybridization in situ
  • Telomerase

ASJC Scopus subject areas

  • Anatomy
  • Cell Biology
  • Histology

Cite this

Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids. / Nieh, Shin; Chen, Su Feng; Fu, Earl; Jan, Chi Ing; Lee, Wei Hua.

In: Acta Cytologica, Vol. 49, No. 1, 2005, p. 31-37.

Research output: Contribution to journalArticle

Nieh, Shin ; Chen, Su Feng ; Fu, Earl ; Jan, Chi Ing ; Lee, Wei Hua. / Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids. In: Acta Cytologica. 2005 ; Vol. 49, No. 1. pp. 31-37.
@article{0a51cc91f44e42d490e427b1ed778b99,
title = "Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids",
abstract = "Objective: To apply in situ hybridization (ISH) detection of human telomerase reverse transcriptase (hTERT) mRNA expression in abnormal cells in body fluids to evaluate its usefulness in the diagnosis of malignant effusions. Study Design: We investigated the expression of hTERT mRNA by ISH in 33 fluid samples from 30 patients, including 1 cerebrospinal fluid, 18 pleural fluids, 1 pericardial fluid, 12 peritoneal fluids and 1 bronchial washing. Comparison of the results of ISH with those of conventional cytologic evaluation was also performed. Results: Cytomorphologic examination of the 33 body fluids allowed classification as malignant, suspicious, atypical and benign conditions. Among the 17 malignant conditions, there were 15 cases positive by both cytology and ISH. There were 9 discrepant cytology-ISH results in patients with various conditions, including 2 cases positive by cytology and inconclusive by ISH, 5 cases suspicious by cytology and positive by ISH, and 2 cases atypical by cytology and negative by ISH. Among the 9 benign conditions, there were 8 cases negative by both cytology and ISH and 1 case negative by cytology and positive by ISH. This test was highly sensitive (90{\%}) and specific (91 {\%}) and had favorable positive (95{\%}) and negative (83{\%}) predictive values. Conclusion: Expression of the hTERT mRNA component can be easily detected by ISH in malignant cells from body fluids. This method is especially useful when the abnormal cell population in the fluid consists of limited numbers of suspicious cells that cannot be completely differentiated from reactive mesothelial cells and thus may help differentiate true positive cases from false negative ones. This ISH method for the detection of expression of the hTERT mRNA component may be an ancillary test for early recognition of cancer cells in body fluids and thus has potential as a diagnostic adjunct in cytopathology.",
keywords = "Body fluids, Fluid cytology, Human telomerase reverse transcriptase, Hybridization in situ, Telomerase",
author = "Shin Nieh and Chen, {Su Feng} and Earl Fu and Jan, {Chi Ing} and Lee, {Wei Hua}",
year = "2005",
language = "English",
volume = "49",
pages = "31--37",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "1",

}

TY - JOUR

T1 - Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids

AU - Nieh, Shin

AU - Chen, Su Feng

AU - Fu, Earl

AU - Jan, Chi Ing

AU - Lee, Wei Hua

PY - 2005

Y1 - 2005

N2 - Objective: To apply in situ hybridization (ISH) detection of human telomerase reverse transcriptase (hTERT) mRNA expression in abnormal cells in body fluids to evaluate its usefulness in the diagnosis of malignant effusions. Study Design: We investigated the expression of hTERT mRNA by ISH in 33 fluid samples from 30 patients, including 1 cerebrospinal fluid, 18 pleural fluids, 1 pericardial fluid, 12 peritoneal fluids and 1 bronchial washing. Comparison of the results of ISH with those of conventional cytologic evaluation was also performed. Results: Cytomorphologic examination of the 33 body fluids allowed classification as malignant, suspicious, atypical and benign conditions. Among the 17 malignant conditions, there were 15 cases positive by both cytology and ISH. There were 9 discrepant cytology-ISH results in patients with various conditions, including 2 cases positive by cytology and inconclusive by ISH, 5 cases suspicious by cytology and positive by ISH, and 2 cases atypical by cytology and negative by ISH. Among the 9 benign conditions, there were 8 cases negative by both cytology and ISH and 1 case negative by cytology and positive by ISH. This test was highly sensitive (90%) and specific (91 %) and had favorable positive (95%) and negative (83%) predictive values. Conclusion: Expression of the hTERT mRNA component can be easily detected by ISH in malignant cells from body fluids. This method is especially useful when the abnormal cell population in the fluid consists of limited numbers of suspicious cells that cannot be completely differentiated from reactive mesothelial cells and thus may help differentiate true positive cases from false negative ones. This ISH method for the detection of expression of the hTERT mRNA component may be an ancillary test for early recognition of cancer cells in body fluids and thus has potential as a diagnostic adjunct in cytopathology.

AB - Objective: To apply in situ hybridization (ISH) detection of human telomerase reverse transcriptase (hTERT) mRNA expression in abnormal cells in body fluids to evaluate its usefulness in the diagnosis of malignant effusions. Study Design: We investigated the expression of hTERT mRNA by ISH in 33 fluid samples from 30 patients, including 1 cerebrospinal fluid, 18 pleural fluids, 1 pericardial fluid, 12 peritoneal fluids and 1 bronchial washing. Comparison of the results of ISH with those of conventional cytologic evaluation was also performed. Results: Cytomorphologic examination of the 33 body fluids allowed classification as malignant, suspicious, atypical and benign conditions. Among the 17 malignant conditions, there were 15 cases positive by both cytology and ISH. There were 9 discrepant cytology-ISH results in patients with various conditions, including 2 cases positive by cytology and inconclusive by ISH, 5 cases suspicious by cytology and positive by ISH, and 2 cases atypical by cytology and negative by ISH. Among the 9 benign conditions, there were 8 cases negative by both cytology and ISH and 1 case negative by cytology and positive by ISH. This test was highly sensitive (90%) and specific (91 %) and had favorable positive (95%) and negative (83%) predictive values. Conclusion: Expression of the hTERT mRNA component can be easily detected by ISH in malignant cells from body fluids. This method is especially useful when the abnormal cell population in the fluid consists of limited numbers of suspicious cells that cannot be completely differentiated from reactive mesothelial cells and thus may help differentiate true positive cases from false negative ones. This ISH method for the detection of expression of the hTERT mRNA component may be an ancillary test for early recognition of cancer cells in body fluids and thus has potential as a diagnostic adjunct in cytopathology.

KW - Body fluids

KW - Fluid cytology

KW - Human telomerase reverse transcriptase

KW - Hybridization in situ

KW - Telomerase

UR - http://www.scopus.com/inward/record.url?scp=12544257172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12544257172&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 31

EP - 37

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 1

ER -